These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31850231)

  • 1. Lateral Lymph Node Metastases in Locally Advanced Low Rectal Cancers May Not Be Treated Effectively With Neoadjuvant (Chemo)Radiotherapy Only.
    Haanappel A; Kroon HM; Schaap DP; Bedrikovetski S; Dudi-Venkata NN; Lee HX; Thomas ML; Liu J; van der Valk MJM; Rutten HJT; Beets GL; Kusters M; Sammour T
    Front Oncol; 2019; 9():1355. PubMed ID: 31850231
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
    Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
    J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
    Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
    Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
    Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
    Kroon HM; Hoogervorst LA; Hanna-Rivero N; Traeger L; Dudi-Venkata NN; Bedrikovetski S; Kusters M; Chang GJ; Thomas ML; Sammour T
    Eur J Surg Oncol; 2022 Jul; 48(7):1475-1482. PubMed ID: 35568607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive lateral pelvic lymph nodes in low rectal cancer: should we change our practice now?
    Gartrell R; Hong MK; Baker A; Master M; Gibbs P; Arslan J; Croxford M; Yeung JM; Faragher IG
    ANZ J Surg; 2021 May; 91(5):947-953. PubMed ID: 33792140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lateral lymph node involvement presents another challenge in rectum cancer in the age of neoadjuvant chemoradiotherapy + total mesorectal excision: an evaluation of survival outcomes.
    Özdemir Ü; Gündoğdu E; Yakar M; Canaz F; Ulaş M; Özer İ
    Langenbecks Arch Surg; 2023 Sep; 408(1):356. PubMed ID: 37702958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic impact of lateral lymph node metastasis at the distal lateral compartment in locally advanced low rectal cancer after neoadjuvant (chemo)radiotherapy.
    Akiyoshi T; Yamaguchi T; Hiratsuka M; Mukai T; Hiyoshi Y; Nagasaki T; Ueno M; Fukunaga Y; Konishi T
    Eur J Surg Oncol; 2021 Dec; 47(12):3157-3165. PubMed ID: 34284904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: results from a multicentre international cohort study.
    Achilli P; Ferrari D; Calini G; Bertoglio CL; Magistro C; Origi M; Carnevali P; Alampi BD; Giusti I; Ferrari G; Calafiore E; Spinelli A; Grass F; Deslarzes P; Hahnloser D; Abdalla S; Larson DW
    Colorectal Dis; 2024 Mar; 26(3):466-475. PubMed ID: 38243617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological Impact of Lateral Lymph Node Dissection After Preoperative Chemoradiotherapy in Patients with Rectal Cancer.
    Kim MJ; Chang GJ; Lim HK; Song MK; Park SC; Sohn DK; Chang HJ; Kim DY; Park JW; Jeong SY; Oh JH
    Ann Surg Oncol; 2020 Sep; 27(9):3525-3533. PubMed ID: 32385767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateral lymph node dissection in advanced low rectal cancer treatment.
    Li J; Shiomi A
    Int J Colorectal Dis; 2021 Nov; 36(11):2361-2371. PubMed ID: 34152455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Significance of Lateral Lymph Node Metastasis in Low Rectal Cancer: a Propensity Score Matching Study.
    Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Yamaguchi S
    J Gastrointest Surg; 2021 Jul; 25(7):1866-1874. PubMed ID: 33078319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of therapeutic strategies for selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in patients with rectal cancer with clinical suspected lateral lymph node metastasis.
    Liu Y; Bao M; Jiang Y; Li F; Xing W; Yang Z; Liu Q
    Front Oncol; 2023; 13():1271463. PubMed ID: 37886180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant Features in Pretreatment Metastatic Lateral Lymph Nodes in Locally Advanced Low Rectal Cancer Predict Distant Metastases.
    Kroon HM; Dudi-Venkata NN; Bedrikovetski S; Liu J; Haanappel A; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Sammour T
    Ann Surg Oncol; 2022 Feb; 29(2):1194-1203. PubMed ID: 34490529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.
    Ogura A; Konishi T; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Beets GL; Rutten HJT; Kusters M;
    J Clin Oncol; 2019 Jan; 37(1):33-43. PubMed ID: 30403572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
    Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
    World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant (chemo)radiotherapy and Lateral Node Dissection: Is It Mutually Exclusive?
    Ogura A; van Oostendorp S; Kusters M
    Clin Colon Rectal Surg; 2020 Nov; 33(6):355-360. PubMed ID: 33162839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distant Metastasis is the Dominant Cause of Treatment Failure after Lateral Lymph Node Dissection in Patients with Lateral Lymph Node Metastasis: Results of the Large Multicenter Lateral Node Study in China.
    Li K; Wang F; Jiang Y; Hong G; Li Z; Liang J; Wu W; Xing W; Liu Q
    J Cancer; 2023; 14(17):3227-3237. PubMed ID: 37928432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.